Status of the company's receivables from Portinho S.A. with payment deadline 1 July 2023
June 30, 2023 11:56 ET
|
Pharma Equity Group A/S
30 June 2023 Announcement no. 36 Status of the company's receivables from Portinho S.A. with payment deadline 1 July 2023 In the consolidated financial statement (with the...
Changes to the Board of Directors in Pharma Equity Group
June 15, 2023 06:00 ET
|
Pharma Equity Group A/S
15 June 2023 Announcement no. 35 Changes to the Board of Directors in Pharma Equity Group Today, the company has received notice that the Chairman of the Board of Directors, Peter Mørch Eriksen...
Ny CMO i Pharma Equity Groups datterselskab Reponex Pharmaceuticals A/S
June 14, 2023 02:30 ET
|
Pharma Equity Group A/S
14. juni 2023 Pressemeddelelse Ny CMO i Pharma Equity Groups datterselskab Reponex Pharmaceuticals A/S Vi er glade for at kunne præsentere Dr. Christopher M Burton MD, Ph.d., (født 1973),...
New CMO in Pharma Equity Groups subsidiary Reponex Pharmaceuticals A/S
June 14, 2023 02:30 ET
|
Pharma Equity Group A/S
14 June 2023 Press Release New CMO in Pharma Equity Groups subsidiary Reponex Pharmaceuticals A/S We are delighted to present Dr Christopher M Burton MD, PhD, (born 1973) an...
Encouraging preliminary data from the first part of a clinical study in pouchitis
June 08, 2023 11:00 ET
|
Pharma Equity Group A/S
8 June 2023 Announcement no. 34 Encouraging preliminary data from the first part of a clinical study in pouchitis The safety and efficacy...
Settlement - Purchase of shares
June 02, 2023 05:52 ET
|
Pharma Equity Group A/S
2 June 2023 Announcement no. 33 Inside information Settlement - purchase of shares In connection with completion of Pharma Equity Group A/S' (the "Company") purchase of Reponex...
Managers’ transactions
May 25, 2023 04:31 ET
|
Pharma Equity Group A/S
May 25,2023 Announcement no. 32 Managers’ transactions Pharma Equity Group A/S has today received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below...
Consolidated interim report 1 January – 31 March 2023
May 10, 2023 00:49 ET
|
Pharma Equity Group A/S
May 10, 2023 Announcement no. 31 Consolidated interim report 1 January – 31 March 2023 Key points (Q1 2023) The transaction with Reponex Pharmaceuticals A/S On 10 May 2023,...
Forløb af ordinær generalforsamling i Pharma Equity Group A/S (”Selskabet”), den 27. april 2023
April 27, 2023 09:31 ET
|
Pharma Equity Group A/S
Pharma Equity Group A/SÅrets meddelelse nr.: 30Dato: 27. april 2023Forløb af ordinær generalforsamling i Pharma Equity Group A/S (”Selskabet”), den 27. april 2023Den 27. april 2023, kl. 14.00 blev der...
Biografi på Professor, overlæge dr. med. Peter Vilmann
April 24, 2023 10:33 ET
|
Pharma Equity Group A/S
Pharma Equity Group A/S Årets meddelelse nr.: 29 Dato: 24. april 2023 Biografi på Professor, overlæge dr. med. Peter Vilmann Med henvisning til meddelelse nr. 28 af 21. april 2023 har Pharma...